Serina Therapeutics, Inc. (SER)

Serina Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.19	7.62	0.53	0.31
Short-Term Investments	-	-	-	1
Cash & Short-Term Investments	3.19	7.62	0.53	1.31
Cash Growth	-57.99%	1331.41%	-59.41%	-
Receivables	0.01	-	-	0
Prepaid Expenses	2.08	-	0.02	0.02
Total Current Assets	5.42	7.62	0.55	1.33
Property, Plant & Equipment	1.12	1.35	0.31	0.51
Total Assets	7.44	8.97	0.86	1.84
Accounts Payable	1.7	0.58	0.14	0.15
Accrued Expenses	1.16	0.57	0.01	0.01
Current Portion of Leases	0.2	0.25	0.13	0.21
Current Unearned Revenue	-	-	0.15	-
Other Current Liabilities	-	0.01	0.01	0
Total Current Liabilities	13.51	1.41	0.44	0.37
Long-Term Debt	0.69	2.98	1.62	-
Long-Term Leases	0.31	0.46	0.06	0.19
Other Long-Term Liabilities	6.74	-	1.08	0.95
Total Liabilities	21.26	4.86	3.19	1.51
Common Stock	0	0.02	0.02	0.02
Additional Paid-In Capital	8	0.86	0.65	0.64
Retained Earnings	-21.78	-33.18	-38.45	-35.76
Total Common Equity	-13.77	-32.29	-37.78	-35.11
Shareholders' Equity	-13.83	4.11	-2.34	0.33
Total Liabilities & Equity	7.44	8.97	0.86	1.84
Total Debt	11.67	3.69	1.81	0.4
Net Cash (Debt)	-8.48	3.92	-1.28	0.91
Net Cash Per Share	-1.48	0.98	-0.60	0.43
Filing Date Shares Outstanding	8.89	8.79	2.22	2.14
Total Common Shares Outstanding	8.89	2.47	2.22	2.14
Working Capital	-8.09	6.21	0.11	0.96
Book Value Per Share	-1.55	-13.09	-17.03	-16.37
Tangible Book Value	-14.28	-32.29	-37.78	-35.11
Tangible Book Value Per Share	-1.61	-13.09	-17.03	-16.37
Machinery	0.88	0.87	0.38	0.37

Source: S&P Capital IQ. Standard template. Financial Sources.